Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) was a blank-check company that completed its initial public offering in 2021, targeting opportunities in the life sciences and biotechnology sector. On May 11, 2023, the company filed a Form 15-12G with the SEC, a notice of termination of registration under Section 12(g) of the Securities Exchange Act, marking the formal conclusion of its registered status as a public SPAC. The deregistration represents the final administrative step in ORIA's lifecycle as a blank-check vehicle focused on biotech deal-making. For full filing history, deal timelines, and sponsor details on ORIA, sign up for complete access at SpacDesk.